PET-CT localizes previously undetectable metastatic lesions in recurrent fallopian tube carcinoma.

Published

Journal Article

BACKGROUND: Fallopian tube carcinoma is a rare malignancy that commonly recurs after initial surgical resection. New combined instrumentation with co-registered PET and CT is a new technique that combines functional and anatomic imaging to detect metastatic disease that may be difficult to detect with either modality alone. CASE: We present two cases of suspected fallopian tube carcinoma recurrence demonstrating the unique potential of combined PET-CT using 18F-fluoro-2-deoxyglucose (FDG). These cases demonstrate the unique capability to detect and localize metastatic disease when serum CA-125, laparoscopy, and CT scan alone were unable to detect recurrence. CONCLUSION: PET-CT with FDG may prove to be a sensitive and accurate method for detection of metastatic disease and may influence the clinical management of recurrent fallopian tube carcinoma.

Full Text

Duke Authors

Cited Authors

  • Patel, PV; Cohade, C; Chin, BB

Published Date

  • December 2002

Published In

Volume / Issue

  • 87 / 3

Start / End Page

  • 323 - 326

PubMed ID

  • 12468334

Pubmed Central ID

  • 12468334

Electronic International Standard Serial Number (EISSN)

  • 1095-6859

International Standard Serial Number (ISSN)

  • 0090-8258

Digital Object Identifier (DOI)

  • 10.1006/gyno.2002.6841

Language

  • eng